(Q24631264)
Statements
BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development (English)
0 references
2013
0 references
3
0 references
4
0 references
347-55
0 references
1 reference
1 reference